Centre Léon-Bérard (UNICANCER)

Phase III PAOLA-1/ENGOT-OV25 Trial: Olaparib Plus Bevacizumab (BEV) As Maintenance Therapy in Patients (PTS) with Newly Diagnosed, Advanced Ovarian Cancer (OC) Treated with Platinum-Based Chemotherapy (PCH) Plus Bev (2020) De Gregorio N, Harter P, Sehouli L, Canzler U, Marme F, Buderath P, Lueck HJ, et al. Conference contribution EANO–EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma (2019) Franceschi E, Hofer S, Brandes AA, Frappaz D, Kortmann RD, Bromberg J, Dangouloff-Ros V, et al. Journal article, Review article Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Gruenewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Multiple new susceptibility loci identified in genome-wide association study of Ewing sarcoma (2018) Machiela MJ, Gruenewald TG, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Conference contribution Salvage Mastectomy Versus Second Conservative Treatment for Second Ipsilateral Breast Tumor Event: A Propensity-Score Matched Cohort Analysis (2018) Levi JMH, Van Limbergen E, Gal J, Schiappa R, Polgar C, Kauer-Dorner D, Pasquier D, et al. Conference contribution Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility (2018) Machiela MJ, Grunewald TGP, Surdez D, Reynaud S, Mirabeau O, Karlins E, Rubio RA, et al. Journal article Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a randomized Phase I study (2017) Higgins M, Curigliano G, Dieras V, Kuemmel S, Kunz G, Fasching P, Campone M, et al. Journal article The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report (2016) Kager L, Whelan J, Dirksen U, Hassan B, Anninga J, Bennister L, Bovee JVMG, et al. Journal article No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, et al. Journal article Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer (2015) Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, Mcguffog L, Mazoyer S, et al. Journal article